BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Abbott Laboratories

Headquarters: Abbott Park, IL, United States
Year Founded: 1900
Status: Public
Industry Sector: HealthTechnology
CEO: Robert B. Ford, MBA
Number Of Employees: 114,000
Enterprise Value: $205,261,280,000
PE Ratio: 16.95
Exchange/Ticker 1: NYSE:ABT
Exchange/Ticker 2: N/A
Latest Market Cap: $226,987,802,624

BioCentury | Dec 12, 2024
Management Tracks

Two more C-suite hires at Xaira

Plus: Accent’s Copeland to retire and updates from ProQR, Kashiv and Aculeus
BioCentury | Nov 21, 2024
Finance

Versant-backed Pep2Tango taking four-way agonist to clinic for obesity

Program designed to reduce weight while sparing muscle mass, GI effects headed for IND next year
BioCentury | Mar 6, 2024
Management Tracks

EyePoint names Ribeiro CMO

Plus: Ford joins Prothena and updates from Atlas, Osmol and CytoVale
BioCentury | Jan 24, 2024
Management Tracks

Markison to succeed Heino as Lantheus CEO

Plus: Lisa Olson becomes CEO of Enthera, and updates from Bayer, Neumora, PDS and more
BioCentury | Dec 7, 2023
Deals

AbbVie sees Cerevel’s antipsychotic as ‘best-in-class’ driver of $8.7B deal

Again investing outside immunology, pharma sees differentiation in potential competitor with Karuna’s registrational schizophrenia therapy
BioCentury | Sep 6, 2023
Management Tracks

Novartis shuffles AbbVie’s Horber in, commercial chief Tschudin out

Latest management changes are part of a broader reshaping of the organization as it seeks greater market share in the U.S.
BioCentury | Mar 30, 2023
Management Tracks

BeiGene hires a global head of diversity and health equity

Plus: Mahmood leaving Nkarta for CEO role and updates from CIRM, CFF 
BioCentury | Nov 22, 2022
Management Tracks

New CEOs named at Oxford, Angelini

Plus: Hegde becomes CSO at Congruence, and updates from Medivir and Grunenthal
BioCentury | Sep 6, 2022
Management Tracks

Owkin names Google’s Vert as chief R&D officer

Plus new chief scientific and medical officer at Ray Therapeutics, and updates from Ansa, Walking Fish and more
BioCentury | May 4, 2022
Management Tracks

Hickey returns to U.S. for new role at Pfizer

Plus Kaundinya named president and CEO at GlycoERA, and updates from Plexium, Alentis, ADCendo, Xcell and more
Items per page:
1 - 10 of 2564